161 related articles for article (PubMed ID: 35651789)
1. Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.
Chen X; Guo J; Zhou F; Ren W; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():905871. PubMed ID: 35651789
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-AL035458.2/hsa-miR-181a-5p Axis-Mediated High Expression of NCAPG2 Correlates With Tumor Immune Infiltration and Non-Small Cell Lung Cancer Progression.
Chen X; Guo J; Ren W; Zhou F; Niu X; Jiang X
Front Oncol; 2022; 12():910437. PubMed ID: 35664767
[TBL] [Abstract][Full Text] [Related]
3. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
Wang W; Bo H; Liang Y; Li G
Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
[TBL] [Abstract][Full Text] [Related]
4. Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma.
Chen X; Guo J; Zhou F; Ren W; Pu J; Mutti L; Niu X; Jiang X
Front Oncol; 2022; 12():895708. PubMed ID: 35646670
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Jiang X; Chen X; Guo J; Zhou F; Pu J; Mutti L; Niu X
Front Mol Biosci; 2022; 9():923584. PubMed ID: 35769906
[TBL] [Abstract][Full Text] [Related]
6. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
9. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
10. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.
Wu X; Sui Z; Zhang H; Wang Y; Yu Z
Front Oncol; 2020; 10():554759. PubMed ID: 33042838
[TBL] [Abstract][Full Text] [Related]
13. Unlocking the role of EIF5A: A potential diagnostic marker regulating the cell cycle and showing negative correlation with immune infiltration in lung adenocarcinoma.
Yang Z; Yuan H; He H; Qi S; Zhu X; Hu X; Jin M; Zhang XX; Yuan ZG
Int Immunopharmacol; 2024 Jan; 126():111227. PubMed ID: 37977067
[TBL] [Abstract][Full Text] [Related]
14. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma.
Wang C; Guo J; Jiang R; Wang C; Pan C; Nie Z; Jiang X
Front Mol Biosci; 2022; 9():895927. PubMed ID: 35685240
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the Role of Shugoshin-Like Protein 1 in Lung Adenocarcinoma: A Comprehensive Analysis and
Yuan Y; Wang J; Zhang D; Tang L; Duan L; Jiang X
Front Oncol; 2022; 12():898920. PubMed ID: 35592680
[TBL] [Abstract][Full Text] [Related]
18. Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.
Chen L; Ren Z; Cai Y
Biomed Res Int; 2021; 2021():4093426. PubMed ID: 33628780
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma.
Liu Y; Xie D; He Z; Zheng L
PeerJ; 2019; 7():e6694. PubMed ID: 31106044
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma.
Chen X; Zhou F; Ren W; Guo J; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():860961. PubMed ID: 35463380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]